Windtree plans to acquire BNB for $500 million

The biopharmaceutical company Windtree Therapeutics has announced its intention to take on debt of up to $500 million to acquire BNB, as part of its cryptocurrency-backed reserve strategy. This operation reflects a growing institutional interest in the Binance token. $BNB